Dolan Matthew Vincent (CIK 0001914994)

Latest company ownership

DXCM - DEXCOM INC
Role: EVP, Strategy & Corporate Dev
Shares held
42,044
Last filed at
Jan 30, 2025
Confidence Score
50.4
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 28, 2025 Jan 30, 2025 DEXCOM INC EVP, Strategy & Corporate Dev Sell 87.5 +1,865 4.64% ✗ $102.8K
May 15, 2024 May 16, 2024 DEXCOM INC EVP Strategy and Corporate Dev Sell 30.0 -2,423 -5.70% ✓ $306.7K
Apr 15, 2024 Apr 16, 2024 DEXCOM INC EVP Strategy and Corporate Dev Sell 35.0 -1,990 -4.49% ✓ $274.2K
Mar 15, 2024 Mar 19, 2024 DEXCOM INC EVP Strategy & Corp Dev Sell 26.3 -4,203 -8.65% ✓ $547.3K
Mar 12, 2024 Mar 14, 2024 DEXCOM INC EVP Strategy and Corporate Sell 40.0 -6,710 -12.14% ✗ $901.9K
Sep 1, 2023 Sep 1, 2023 DEXCOM INC SVP Corporate Strategy-Develop Sell 55.0 -56 -0.17% ✓ $5.7K
Mar 16, 2023 Mar 17, 2023 DEXCOM INC SVP Corporate Strategy-Develop Sell 30.0 -2,303 -6.42% ✓ $264.8K
Mar 10, 2023 Mar 14, 2023 DEXCOM INC SVP Corporate Strategy-Develop Sell 5.0 -12,433 -25.74% ✓ $1.4M
Mar 6, 2023 Mar 6, 2023 DEXCOM INC SVP Corporate Strategy-Develop Sell 51.3 -226 -0.84% ✓ $25.9K
Sep 1, 2022 Sep 6, 2022 DEXCOM INC SVP Corporate Strategy-Develop Sell 58.8 -5 -0.02% ✓ $408.2
Mar 15, 2022 Mar 17, 2022 DEXCOM INC SVP Corporate Development Sell 12.5 -2,186 -24.78% ✓ $928.4K
Mar 8, 2022 Mar 10, 2022 DEXCOM INC SVP Corporate Development Sell 97.5 +1,274 16.88% ✗ $655.8K